Renaissance Technologies
MAIA icon

Renaissance Technologies’s MAIA Biotechnology MAIA Stock Holding History

Renaissance Technologies’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19,000
Closed -$42K – 3784
2024
Q1 		$42K Sell
19,000
-92,200
-83% -$138K ﹤0.01% 3506
2023
Q4 		$130K Buy
+111,200
New +$179K ﹤0.01% 3240
2023
Q3 		– Sell
-10,800
Closed -$24K – 3920
2023
Q2 		$24K Sell
10,800
-9,850
-48% -$26.3K ﹤0.01% 3738
2023
Q1 		$71K Buy
+20,650
New +$84.9K ﹤0.01% 3584

Other funds holding MAIA

HFF
Halter Ferguson Financial Carmel, Indiana $456M AUM 49.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
NW
Naviter Wealth Little Rock, Arkansas $801M AUM 22.2% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Renaissance Technologies's MAIA Position: Q2 2024 in Review

Renaissance Technologies sold out of MAIA Biotechnology (MAIA) in Q2 2024, closing a stake of 19,000 shares — an estimated $42K sold.

Renaissance Technologies first reported a position in MAIA in Q1 2023 and held it in 4 quarters. The position peaked at $130K in Q4 2023. 21 funds tracked by Wall St. Rank hold MAIA as of Q2 2024.

  • Renaissance Technologies reported no remaining MAIA Biotechnology position as of Q2 2024 after selling out during the quarter.
  • Renaissance Technologies sold 19,000 MAIA Biotechnology shares in Q2 2024, an estimated $42K.
  • Renaissance Technologies first reported a position in MAIA Biotechnology in Q1 2023 and held it in 4 quarters.
  • Renaissance Technologies's MAIA Biotechnology position peaked at $130K in Q4 2023.
  • 21 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2024.

Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.